go-v.orgdoi

Factors affecting stability testing of drugs and degradation study guidelines

Pankaj Bhamare, Sandip Bodkhe · European journal of parenteral & pharmaceutical sciences · 2026

  • DOI 10.37521/ejpps31309
  • Publisher OpenAlex
  • Type article
  • Issued 2026

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

European journal of parenteral & pharmaceutical sciences · OpenAlex · article · 2026

Abstract

Stability testing is critical for ensuring that pharmaceutical products remain safe, potent, and effective throughout their shelf life. Drug degradation can occur due to various intrinsic (chemical structure) and extrinsic (temperature, humidity, light, pH) factors. This review examines the principal factors affecting drug stability, regulatory guidelines from the International Council for Harmonisation (ICH), Brazilian National Health Surveillance Agency (ANVISA), and China, as well as forced degradation methodologies. Accelerated stability testing provides rapid prediction of product shelf life under stress conditions, while real-time studies ensure long-term safety.

Recent product recalls illustrate the critical importance of comprehensive stability assessment and root cause analysis. We synthesize current knowledge on stability-indicating analytical methods, regulatory compliance strategies, and emerging practices to support pharmaceutical development and quality assurance. This review encompasses intrinsic factors (chemical structure, polymorphism), environmental factors (temperature, humidity, light, pH), excipient interactions, accelerated and forced degradation protocols, and practical case studies demonstrating real-world applications.

Keywords: Stability Testing, Drug Shelf Life, ICH Guidelines, ANVISA Guidelines, Accelerated Stability, Forced Degradation.

Open the resolved locator · 10.37521/ejpps31309

Metadata licence: OpenAlex metadata (CC0)